Bliss GVS Pharma Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 1,634.37 Crore) operating in Pharmaceuticals sector. Bliss GVS Pharma Ltd. key Products/Revenue ...

It is notoriously hard to treat effectively. Saphnelo will compete in the market most closely with GlaxoSmithKline's BLyS inhibitor Benlysta (belimumab), which has been available in the EU to ...